Pharmaceuticals

US stock futures are lower this morning, after Thursday's House budget vote on the US debt ceiling was rescheduled. Futures for the Dow Jones Industrial Average dipped 55 points to 12,138.00 and S&P 500 index futures fell 5.70 points to 1,291.10. Nasdaq 100 futures dropped 7.75 points to 2,362....

Chevron Corporation (NYSE: CVX) is projected to report its Q2 EPS at $3.56 on revenue of $71.58 billion. Aon Corporation (NYSE: AON) is expected to report its Q2 EPS at $0.82 on revenue of $2.74 billion. Newell Rubbermaid Inc (NYSE: NWL) is estimated to report its Q2 EPS at $0.42 on revenue of $...

Some of the stocks that may grab investor focus today are: Wall Street expects Merck & Company Inc (NYSE: MRK) to report its Q2 EPS at $0.95 on revenue of $11.78 billion. Merck shares dropped 0.74% to close at $34.93 yesterday. Starbucks Corp (NASDAQ: SBUX) reported its Q2 profit at $279...

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) today confirmed that the U.S. Food and Drug Administration approved dosing recommendations for OFIRMEV injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg. Cadence's announcement follows the issuance of a news release...

Pfizer (NYSE: PFE) announces its next round of earnings this Tuesday, August 2, 2011. Here is Benzinga's everything-that-matters guide for this Tuesday's second quarter earnings announcement. Earnings and Revenue: Based on estimates, investors are readying for a positive EPS reading of 59...

Merlin Nexus and New Leaf Venture Partners, stockholders in Icagen, Inc. (Nasdaq: ICGN), disclosed today a letter submitted to the Icagen Board contesting the Company's planned acquisition by Pfizer Inc (NYSE: PFE). According to a July 20, 2011 press announcement, Pfizer plans to purchase the 8.3...

Teva Pharmaceuticals USA, the U.S.–based generic arm of Teva Pharmaceuticals (NASDAQ: TEVA) announced that it will sell Camrese as the Authorized Generic of Seasonique® which is also manufactured by Teva Pharmaceuticals. This product will continue to be manufactured under the brand product's new...

According to a tweet from @markflowchatter, Financial Times Mergermarket is reporting that Teva (NASDAQ: TEVA) is in talks to purchase Spectrum Pharma (NASDAQ: SPPI). This article may include mentions of rumors, chatter, or unconfirmed information. Readers should beware that while unconfirmed...

Kellogg Co (NYSE: K) reported a 14% rise in its second-quarter profit. Kellogg reported its quarterly profit at $343 million, or $0.94 per share, up from $302 million, or $0.79 per share, in the year-ago period. Its sales climbed 11% to $3.39 billion. However, analysts were expecting a profit of $0...

Bristol-Myers Squibb Co (NYSE: BMY) reported upbeat second-quarter earnings and lifted its 2011 projections. Bristol-Myers reported its quarterly earnings at $902 million, or $0.52 per share, down from $927 million, or $0.53 per share, in the year-earlier period. Its revenue surged 14% y/y to $5....

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced that the companies have submitted their reply to a complete response letter issued in October 2010 by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (...

Astrazeneca PLC (NYSE: AZN) is expected to report its Q2 EPS at $1.80 on revenue of $8.19 billion. Exxon Mobil Corporation (NYSE: XOM) is projected to report its Q2 EPS at $2.33 on revenue of $121.39 billion. Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report its Q2 EPS at $0.55 on...

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels and entry/exit points become more clearly defined. The following stocks hit new 52-week highs in Wednesday's trading session (listed from highest total volume to...

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Gemcitabine for Injection (200 mg/vial and 1 g/vial), a bioequivalent generic version of Gemzar®* in the US market on July 25, 2011, following the approval by the United States Food & Drug Administration (USFDA) of Dr....

Here are today's Put/Call Ratio leaders… 1. Liberty Media (NASDAQ: LINTA) 12,100 puts, 38 calls 2. Collective Brands (NYSE: PSS) 4,398 puts, 53 calls 3. CarMax Group (NYSE: KMX) 5,724 puts 84 calls 4. Telvent GIT SA (NASDAQ: TLVT) 2,910 puts, 50 calls 5. Warner Chilcott (NASDAQ: WCRX) 3,067 puts,...